Desq Long
Sign in
SEC FORM 4
$206,906.25

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Acquisition (code M) of 9,375 shares at $22.07 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Dianthus Therapeutics, Inc. /DE/ (DNTH)." Disclosed 2026-09-03. https://desqlong.com/cards/0001992260-26-000009-3 (retrieved 2026-09-26).